July 24th, 2020We have released Oracle Clinical version 5.2 in a fully qualified Azure Cloud Environment The Oracle Clinical version 5.2…
July 22th, 2020We operate in a fully qualified Azure Cloud Environment. We host all of our applications and services in compliance with…
June 30th, 2020ID-HUB media spoke with José Javier García, Pivotal´s VP, Data Management and Biostatistics, about adaptive study design and the potential…
June 8th, 2020The phase II, multicenter, open-label, randomized and controlled clinical trial will research whether BDB-001, a recombinant injectable humanized anti-human C5a…
May 25th, 2020Pivotal has adhered to the Alliance for Children´s Vaccination Pivotal collaborates along with Gavi, an international organization and global Vaccine…
May 11th, 2020If you would like to read the full article please go to the following link: ICT media (This article is extracted from International…
April 28th, 2020The clinical trial, which plans to include a total of up to 300 patients, has recently begun to include the…
March 3th, 2020New patients´ enrollment model to accelerate drug development Pivotal announced today the acquisition of Akcelis BVBA, a leading full-service…
February 12th, 2020The annual conference was held in San Francisco (California) Pivotal, represented by members of our Senior Management, has participated…
February 11th, 2020Two multinational multicenter clinical studies launched early 2020 to support regulatory clearance of EsoGuard/EsoCheck as an FDA-registered In-Vitro Diagnostic (IVD)…